Icmr Clinical Trials
- All
- News
- Videos
-
India Close To Launching Dengue Vaccine, Final Trials Underway
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Tissue Sample Moved 37 Km In 20 Min, Mid-Surgery, For Cancer Testing
The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.
-
India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
-
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
-
India Close To Launching Dengue Vaccine, Final Trials Underway
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Tissue Sample Moved 37 Km In 20 Min, Mid-Surgery, For Cancer Testing
The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.
-
India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
-
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
